Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 353

1.

Controlled systemic delivery of indomethacin using membrane-moderated, cream formulation-based transdermal devices.

Rao PR, Chalasani KB, Chauhan AS, Jain AK, Diwan PV, Ram MK.

Drug Deliv. 2006 May-Jun;13(3):207-13.

PMID:
16556573
[PubMed - indexed for MEDLINE]
2.

Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug.

Patel NA, Patel NJ, Patel RP.

Drug Dev Ind Pharm. 2009 Feb;35(2):234-42. doi: 10.1080/03639040802266782 .

PMID:
18785045
[PubMed - indexed for MEDLINE]
3.

Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration.

Rao PR, Diwan PV.

Drug Dev Ind Pharm. 1998 Apr;24(4):327-36.

PMID:
9876592
[PubMed - indexed for MEDLINE]
4.
5.

Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride.

Kusum Devi V, Saisivam S, Maria GR, Deepti PU.

Drug Dev Ind Pharm. 2003 May;29(5):495-503.

PMID:
12779279
[PubMed - indexed for MEDLINE]
6.

Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.

Babu RJ, Pandit JK.

Int J Pharm. 2005 Jan 20;288(2):325-34. Epub 2004 Dec 16.

PMID:
15620873
[PubMed - indexed for MEDLINE]
7.

Transdermal delivery of indomethacin by iontophoresis.

Kanebako M, Inagi T, Takayama K.

Biol Pharm Bull. 2002 Jun;25(6):779-82.

PMID:
12081146
[PubMed - indexed for MEDLINE]
Free Article
8.

Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.

Suedee R, Bodhibukkana C, Tangthong N, Amnuaikit C, Kaewnopparat S, Srichana T.

J Control Release. 2008 Aug 7;129(3):170-8. doi: 10.1016/j.jconrel.2008.05.001. Epub 2008 May 10.

PMID:
18550193
[PubMed - indexed for MEDLINE]
9.

Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.

Mutalik S, Udupa N.

J Pharm Pharm Sci. 2005 Jan 21;8(1):26-38.

PMID:
15946595
[PubMed - indexed for MEDLINE]
Free Article
10.

Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.

Shakeel F, Ramadan W, Ahmed MA.

J Drug Target. 2009 Jul;17(6):435-41. doi: 10.1080/10611860902963021.

PMID:
19527114
[PubMed - indexed for MEDLINE]
11.

Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.

Narishetty ST, Panchagnula R.

Biopharm Drug Dispos. 2004 Jan;25(1):9-20.

PMID:
14716748
[PubMed - indexed for MEDLINE]
12.

Transdermal delivery and accumulation of indomethacin in subcutaneous tissues in rats.

Mikulak SA, Vangsness CT, Nimni ME.

J Pharm Pharmacol. 1998 Feb;50(2):153-8.

PMID:
9530982
[PubMed - indexed for MEDLINE]
13.

Permeability studies of cellulose acetate free films for transdermal use: influence of plasticizers.

Rao PR, Diwan PV.

Pharm Acta Helv. 1997 Feb;72(1):47-51.

PMID:
9063088
[PubMed - indexed for MEDLINE]
14.

Percutaneous absorption of acemetacin from a membrane controlled transdermal system and prediction of the disposition of the drug in rats.

Ito Y, Ogiso T, Iwaki M, Tanino T, Terao M.

Biol Pharm Bull. 1993 Jun;16(6):583-8.

PMID:
8364511
[PubMed - indexed for MEDLINE]
15.

Formulation and evaluation of flurbiprofen microemulsion.

Ambade KW, Jadhav SL, Gambhire MN, Kurmi SD, Kadam VJ, Jadhav KR.

Curr Drug Deliv. 2008 Jan;5(1):32-41.

PMID:
18220549
[PubMed - indexed for MEDLINE]
16.

Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.

Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, Diwan PV.

J Control Release. 2003 Jul 31;90(3):335-43.

PMID:
12880700
[PubMed - indexed for MEDLINE]
17.

Effect of pulsed output ultrasound on the transdermal absorption of indomethacin from an ointment in rats.

Asano J, Suisha F, Takada M, Kawasaki N, Miyazaki S.

Biol Pharm Bull. 1997 Mar;20(3):288-91.

PMID:
9084890
[PubMed - indexed for MEDLINE]
18.

Pharmacokinetic profile of a new matrix-type transdermal delivery system: diclofenac diethyl ammonium patch.

Devi K, Paranjothy KL.

Drug Dev Ind Pharm. 1999 May;25(5):695-700.

PMID:
10219542
[PubMed - indexed for MEDLINE]
19.

Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.

Cho CW, Choi JS, Yang KH, Shin SC.

Arch Pharm Res. 2009 May;32(5):747-53. doi: 10.1007/s12272-009-1514-5. Epub 2009 May 27.

PMID:
19471890
[PubMed - indexed for MEDLINE]
20.

Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.

Limpongsa E, Umprayn K.

AAPS PharmSciTech. 2008;9(2):464-70. doi: 10.1208/s12249-008-9062-8. Epub 2008 Mar 14.

PMID:
18431661
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk